HARROW, INC. — Director's Dealing 2017

Feb 4, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2017-02-01

Reporting Person: BAUM MARK L (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-01	Option - Right to Buy	$2.23	A	160000	Acquired	2027-02-01	Common Stock (160000)	Direct

Footnotes

F1: Represents stock options granted under the Issuer's 2007 Stock Incentive and Awards Plan. The stock options vest in equal quarterly installments over a three year period.